AstraZeneca

Ironwood long-term outlook positive, says Ladenburg
Yahoo/Fly on the Wall
Tue, 10/23/12 - 04:29 pm
Ironwood Pharmaceuticals
linaclotide
AstraZeneca
China
3 Diabetes Phase 3 Wins
Motley Fool
Tue, 10/23/12 - 04:19 pm
Merck
Sanofi
Eli Lilly
diabetes
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Amylin
China Biotech In Review: Pharmaron Announces Multi-Year Drug Discovery Partnership With AstraZeneca
Seeking Alpha
Sun, 10/21/12 - 11:07 am
Pharmaron
LifeTech Scientific
Fosun Pharmaceutical
Shenzhen Hepalink Pharmaceutical
ProMetic Life Sciences
TNI BioTech
AstraZeneca
WuXi AppTech
Complete Genomics
Illumina
4 European Pharmaceuticals Paying Substantial Dividends
Seeking Alpha
Sun, 10/21/12 - 10:53 am
AstraZeneca
GSK
Novartis
Sanofi
CRL/AstraZeneca Join Forces
Yahoo/Zacks
Sat, 10/20/12 - 10:27 am
Charles River Laboratories
AstraZeneca
AstraZeneca Expands R&D in China to Boost Drug Discovery
Bloomberg
Mon, 10/15/12 - 11:44 am
R&D
China
AstraZeneca
Should I Buy AstraZeneca?
Motley Fool
Sat, 10/13/12 - 12:30 pm
AstraZeneca
Pharmas Across The Pond
Motley Fool
Sat, 10/13/12 - 12:30 pm
AstraZeneca
GSK
Sanofi
Bristol Myers' Competition Causes Increased Risk
Seeking Alpha
Thu, 10/11/12 - 11:39 am
Bristol-Myers Squibb
Pfizer
Sanofi
Eli Lilly
AstraZeneca
MedImmune partners on trials for a new slate of cancer immunotherapy combos
Fierce Biotech
Wed, 10/10/12 - 12:00 pm
cancer immunotherapy
MedImmune
AstraZeneca
Eli Lilly Sees A Ray Of Hope But The Stock Is Ahead Of Itself
Seeking Alpha
Wed, 10/10/12 - 11:37 am
Eli Lilly
AstraZeneca
GSK
JNJ
Merck
Pfizer
AstraZeneca bags license to Ardelyx kidney drugs
Pharma Times, UK
Mon, 10/8/12 - 12:14 pm
AstraZeneca
Ardelyx
NHE3 inhibitors
Regulus Therapeutics: Serious Red Flags At This Public Offering
Seeking Alpha
Mon, 10/8/12 - 10:41 am
Regulus
stock offering
Sanofi
GSK
AstraZeneca
AstraZeneca’s New Strategy
Wall Street Cheat Street
Sun, 10/7/12 - 11:52 am
AstraZeneca
[video]Is This Big Pharma Going Shopping?
Motley Fool
Wed, 10/3/12 - 12:38 pm
M&A
AstraZeneca
Abbott Labs
Eli Lilly
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha
Wed, 10/3/12 - 10:50 am
patents
Bristol-Myers Squibb
Amylin
AstraZeneca
Novo Nordisk
Eli Lilly
Merck
IPO Preview: Regulus Therapeutics
Seeking Alpha
Wed, 10/3/12 - 10:45 am
IPOs
Regulus
AstraZeneca
AstraZeneca Will Rise Again
Seeking Alpha
Wed, 10/3/12 - 10:44 am
AstraZeneca
J&J Experimental Diabetes Drug Helps High-Risk Patients
Bloomberg
Tue, 10/2/12 - 10:05 am
diabetes
JNJ
canagliflozin
Dapagliflozin
Bristol-Myers Squibb
AstraZeneca
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
Seekin Alpha
Mon, 10/1/12 - 09:52 pm
M&A
AstraZeneca
Seattle Genetics
Regeneron
ONYX Pharmaceuticals
Biomarin
Forest Labs

Pages